Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Factors associated with antihypertensive medication non-adherence: a systematic review

Abstract

Non-adherence to antihypertensive medication is the most important cause of uncontrolled blood pressure and is influenced by multiple interrelating factors. Understanding the complexity of medication non-adherence and its associated factors is important to determine intervention strategies. Therefore, a systematic review was performed aimed to identify factors associated with antihypertensive medication non-adherence. Different databases were searched for observational studies reporting on factors associated with non-adherence to antihypertensive medication. Titles, abstracts and full texts were reviewed by three researchers. Subsequently, the methodological quality of each study was assessed. Factors that were extracted from the included studies were categorised as factors with consistent or inconsistent evidence to put their potential importance into perspective. Forty-four studies were included. Higher co-payment, side effects and a poor patient–provider relationship were identified as factors with consistent evidence since consistent significant relationships were found for these factors whenever studied. The relationships between non-adherence and multiple other factors were inconsistent among the reviewed studies. However, some of these factors deserve some consideration. Since multiple potentially relevant factors were identified, patient-tailored interventions focussing on identifying and addressing patients’ specific barriers to adherence are needed. Further research should clarify the influence of inconsistent factors on adherence and their potential to be addressed in interventions.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. World Health Organization A global brief on hypertension. Silent killer, global public health crisis. World Health Organization: Geneva, 2013.

  2. Sabate E . Adherence to long term therapies. Evidence for action. World Health Organization: Geneva, 2003.

    Google Scholar 

  3. Law MR, Morris JK, Wald NJ . Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338: b1665.

    Article  CAS  Google Scholar 

  4. Dragomir A, Cote R, Roy L, Blais L, Lalonde L, Berard A et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care 2010; 48: 418–425.

    Article  Google Scholar 

  5. Chowdhury R, Khan H, Heydon E, Shroufi A, Fahimi S, Moore C et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J 2013; 34 (38): 2940–2948.

    Article  CAS  Google Scholar 

  6. Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012; 73 (5): 691–705.

    Article  Google Scholar 

  7. Naderi SH, Bestwick JP, Wald DS . Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376 162 patients. Am J Med 2012; 125 (9): 882–887.e1.

    Article  Google Scholar 

  8. Bowry AD, Shrank WH, Lee JL, Stedman M, Choudhry NK . A systematic review of adherence to cardiovascular medications in resource-limited settings. J Gen Intern Med 2011; 26 (12): 1479–1491.

    Article  Google Scholar 

  9. Lemstra M, Alsabbagh MW . Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis. Patient Prefer Adherence 2014; 8: 211–218.

    Article  Google Scholar 

  10. AlGhurair SA, Hughes CA, Simpson SH, Guirguis LM . A systematic review of patient self-reported barriers of adherence to antihypertensive medications using the world health organization multidimensional adherence model. J Clin Hypertens (Greenwich) 2012; 14 (12): 877–886.

    Article  Google Scholar 

  11. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62 (10): 1006–1012.

    Article  Google Scholar 

  12. Thomas BH, Ciliska D, Dobbins M, Micucci S . A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldviews Evid Based Nurs 2004; 1 (3): 176–184.

    Article  CAS  Google Scholar 

  13. Adams AS, Uratsu C, Dyer W, Magid D, O'Connor P, Beck A et al. Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users. JAMA Intern Med 2013; 173 (1): 54–61.

    Article  Google Scholar 

  14. Baggarly SA, Kemp RJ, Wang X, Magoun AD . Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population. Res Social Adm Pharm 2014; 10 (6): e99–e112.

    Article  Google Scholar 

  15. Bailey JE, Hajjar M, Shoib B, Tang J, Ray MM, Wan JY . Risk factors associated with antihypertensive medication nonadherence in a statewide Medicaid population. Am J Med Sci 2014; 348 (5): 410–415.

    Article  Google Scholar 

  16. Bailey JE, Lee MD, Somes GW, Graham RL . Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care. Clin Therapeut 1996; 18 (6): 1252–1262.

    Article  CAS  Google Scholar 

  17. Crowley MJ, Grubber JM, Olsen MK, Bosworth HB . Factors associated with non-adherence to three hypertension self-management behaviors: preliminary data for a new instrument. J Gen Intern Med 2013; 28 (1): 99–106.

    Article  Google Scholar 

  18. Cuffee YL, Angner E, Oliver N, Plummer D, Kiefe C, Hullett S et al. Does happiness predict medication adherence among African Americans with hypertension? Appl Res Qual Life 2012; 7 (4): 403–412.

    Google Scholar 

  19. Cuffee YL, Hargraves JL, Rosal M, Briesacher BA, Schoenthaler A, Person S et al. Reported racial discrimination, trust in physicians, and medication adherence among inner-city African Americans with hypertension. Am J Public Health 2013; 103 (11): e55–e62.

    Article  Google Scholar 

  20. Forsyth J, Schoenthaler A, Chaplin WF, Ogedegbe G, Ravenell J . Perceived discrimination and medication adherence in black hypertensive patients: the role of stress and depression. Psychosom Med 2014; 76 (3): 229–236.

    Article  Google Scholar 

  21. Holmes HM, Luo R, Hanlon JT, Elting LS, Suarez-Almazor M, Goodwin JS . Ethnic disparities in adherence to antihypertensive medications of medicare part D beneficiaries. J Am Geriatr Soc 2012; 60 (7): 1298–1303.

    Article  Google Scholar 

  22. Holt E, Joyce C, Dornelles A, Morisky D, Webber LS, Muntner P et al. Sex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc 2013; 61 (4): 558–564.

    Article  Google Scholar 

  23. Holt EW, Muntner P, Joyce CJ, Webber L, Krousel-Wood MA . Health-related quality of life and antihypertensive medication adherence among older adults. Age Ageing 2010; 39 (4): 481–487.

    Article  Google Scholar 

  24. Hyre AD, Krousel-Wood MA, Muntner P, Kawasaki L, DeSalvo KB . Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens (Greenwich) 2007; 9 (3): 179–186.

    Article  Google Scholar 

  25. Ishisaka DY, Jukes T, Romanelli RJ, Wong KS, Schiro TA . Disparities in adherence to and persistence with antihypertensive regimens: an exploratory analysis from a community-based provider network. J Am Soc Hypertens 2012; 6 (3): 201–209.

    Article  Google Scholar 

  26. Kim EY, Han HR, Jeong S, Kim KB, Park H, Kang E et al. Does knowledge matter? Intentional medication nonadherence among middle-aged Korean Americans with high blood pressure. J Cardiovasc Nurs 2007; 22 (5): 397–404.

    Article  Google Scholar 

  27. Kressin NR, Wang F, Long J, Bokhour BG, Orner MB, Rothendler J et al. Hypertensive patients' race, health beliefs, process of care, and medication adherence. J Gen Intern Med 2007; 22 (6): 768–774.

    Article  Google Scholar 

  28. Krousel-Wood M, Islam T, Muntner P, Holt E, Joyce C, Morisky DE et al. Association of depression with antihypertensive medication adherence in older adults: cross-sectional and longitudinal findings from CoSMO. Ann Behav Med 2010; 40 (3): 248–257.

    Article  Google Scholar 

  29. Krousel-Wood M, Joyce C, Holt E, Muntner P, Webber LS, Morisky DE et al. Predictors of decline in medication adherence: results from the cohort study of medication adherence among older adults. Hypertension 2011; 58 (5): 804–810.

    Article  CAS  Google Scholar 

  30. Lewis LM, Schoenthaler AM, Ogedegbe G . Patient factors, but not provider and health care system factors, predict medication adherence in hypertensive black men. J Clin Hypertens (Greenwich) 2012; 14 (4): 250–255.

    Article  Google Scholar 

  31. Li WW, Stewart AL, Stotts N, Froelicher ES . Cultural factors associated with antihypertensive medication adherence in chinese immigrants. J Cardiovasc Nurs 2006; 21 (5): 354–362.

    Article  Google Scholar 

  32. Maciejewski ML, Bryson CL, Perkins M, Blough DK, Cunningham FE, Fortney JC et al. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications. Am J Manag Care 2010; 16 (1): e20–e34.

    PubMed  Google Scholar 

  33. Morris AB, Li J, Kroenke K, Bruner-England TE, Young JM, Murray MD . Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy 2006; 26 (4): 483–492.

    Article  Google Scholar 

  34. Phillips LA, Leventhal H, Leventhal EA . Assessing theoretical predictors of long-term medication adherence: patients' treatment-related beliefs, experiential feedback and habit development. Psychol Health 2013; 28 (10): 1135–1151.

    Article  Google Scholar 

  35. Ren XS, Kazis LE, Lee A, Zhang H, Miller DR . Identifying patient and physician characteristics that affect compliance with antihypertensive medications. J Clin Pharm Ther 2002; 27 (1): 47–56.

    Article  CAS  Google Scholar 

  36. Richardson MP, Waring ME, Wang ML, Nobel L, Cuffee Y, Person SD et al. Weight-based discrimination and medication adherence among low-income African Americans with hypertension: how much of the association is mediated by self-efficacy? Ethn Dis 2014; 24 (2): 162–168.

    PubMed  Google Scholar 

  37. Roumie CL, Greevy R, Wallston KA, Elasy TA, Kaltenbach L, Kotter K et al. Patient centered primary care is associated with patient hypertension medication adherence. J Behav Med 2011; 34 (4): 244–253.

    Article  Google Scholar 

  38. Schoenthaler A, Chaplin WF, Allegrante JP, Fernandez S, Diaz-Gloster M, Tobin JN et al. Provider communication effects medication adherence in hypertensive African Americans. Patient Educ Couns 2009; 75 (2): 185–191.

    Article  Google Scholar 

  39. Shaya FT, Du D, Gbarayor CM, Frech-Tamas F, Lau H, Weir MR . Predictors of compliance with antihypertensive therapy in a high-risk medicaid population. J Natl Med Assoc 2009; 101 (1): 34–39.

    Article  Google Scholar 

  40. Siegel D, Lopez J, Meier J . Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med 2007; 120 (1): 26–32.

    Article  Google Scholar 

  41. Steiner JF, Ho PM, Beaty BL, Dickinson LM, Hanratty R, Zeng C et al. Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circ Cardiovasc Qual Outcomes 2009; 2 (5): 451–457.

    Article  Google Scholar 

  42. Taira DA, Gelber RP, Davis J, Gronley K, Chung RS, Seto TB . Antihypertensive adherence and drug class among Asian Pacific Americans. Ethn Health 2007; 12 (3): 265–281.

    Article  Google Scholar 

  43. Taira DA, Wong KS, Frech-Tamas F, Chung RS . Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care. Am J Manag Care 2006; 12 (11): 678–683.

    PubMed  Google Scholar 

  44. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J . Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med 2002; 17 (7): 504–511.

    Article  Google Scholar 

  45. Xie L, Frech-Tamas F, Marrett E, Baser O . A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy. Curr Med Res Opin 2014; 30 (12): 2415–2422.

    Article  CAS  Google Scholar 

  46. Lowry KP, Dudley TK, Oddone EZ, Bosworth HB . Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother 2005; 39 (7–8): 1198–1203.

    Article  Google Scholar 

  47. Trivedi RB, Ayotte B, Edelman D, Bosworth HB . The association of emotional well-being and marital status with treatment adherence among patients with hypertension. J Behav Med 2008; 31 (6): 489–497.

    Article  Google Scholar 

  48. Calderón-Larrañaga A, Diaz E, Poblador-Plou B, Gimeno-Feliu LA, Abad-Díez JM, Prados-Torres A . Non-adherence to antihypertensive medication: the role of mental and physical comorbidity. Int J Cardiol 2016; 207: 310–316.

    Article  Google Scholar 

  49. Gentil L, Vasiliadis HM, Preville M, Bosse C, Berbiche D . Association between depressive and anxiety disorders and adherence to antihypertensive medication in community-living elderly adults. J Am Geriatr Soc 2012; 60 (12): 2297–2301.

    Article  Google Scholar 

  50. Hedna K, Hakkarainen KM, Gyllensten H, Jonsson AK, Andersson Sundell K, Petzold M et al. Adherence to antihypertensive therapy and elevated blood pressure: should we consider the use of multiple medications? PLoS One 2015; 10 (9): e0137451.

    Article  Google Scholar 

  51. Kivimaki M, Batty GD, Hamer M, Nabi H, Korhonen M, Huupponen R et al. Influence of retirement on nonadherence to medication for hypertension and diabetes. CMAJ 2013; 185 (17): E784–E790.

    Article  Google Scholar 

  52. Nabi H, Vahtera J, Singh-Manoux A, Pentti J, Oksanen T, Gimeno D et al. Do psychological attributes matter for adherence to antihypertensive medication? The Finnish Public Sector Cohort Study. J Hypertens 2008; 26 (11): 2236–2243.

    Article  CAS  Google Scholar 

  53. Lotsch F, Auer-Hackenberg L, Groger M, Rehman K, Morrison V, Holmes E et al. Adherence of patients to long-term medication: a cross-sectional study of antihypertensive regimens in Austria. Wien Klin Wochenschr 2015; 127 (9–10): 379–384.

    Article  Google Scholar 

  54. Maguire LK, Hughes CM, McElnay JC . Exploring the impact of depressive symptoms and medication beliefs on medication adherence in hypertension—a primary care study. Patient Educ Couns 2008; 73 (2): 371–376.

    Article  Google Scholar 

  55. Morrison VL, Holmes EA, Parveen S, Plumpton CO, Clyne W, De Geest S et al. Predictors of self-reported adherence to antihypertensive medicines: a multinational, cross-sectional survey. Value Health 2015; 18 (2): 206–216.

    Article  Google Scholar 

  56. Natarajan N, Putnam W, Van Aarsen K, Beverley Lawson K, Burge F . Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension. Can Fam Physician 2013; 59 (2): e93–e100.

    PubMed  PubMed Central  Google Scholar 

  57. Lemstra M, Blackburn D, Crawley A, Fung R . Proportion and risk indicators of nonadherence to statin therapy: a meta-analysis. Can J Cardiol 2012; 28 (5): 574–580.

    Article  Google Scholar 

  58. Gellad WF, Grenard JL, Marcum ZA . A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother 2011; 9 (1): 11–23.

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank the Royal Dutch Pharmacists Association for financial support and medical librarian Rene Otten for supporting the development of the search strategy and database search. This work was financially supported by the Royal Dutch Pharmacists Association.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D M van der Laan.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Journal of Human Hypertension website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

van der Laan, D., Elders, P., Boons, C. et al. Factors associated with antihypertensive medication non-adherence: a systematic review. J Hum Hypertens 31, 687–694 (2017). https://doi.org/10.1038/jhh.2017.48

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2017.48

This article is cited by

Search

Quick links